These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12492616)

  • 1. Adverse drug reactions and off-label drug use in paediatric outpatients.
    Horen B; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2002 Dec; 54(6):665-70. PubMed ID: 12492616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off label and unlicensed drug use among French office based paediatricians.
    Chalumeau M; Tréluyer JM; Salanave B; Assathiany R; Chéron G; Crocheton N; Rougeron C; Mares M; Bréart G; Pons G
    Arch Dis Child; 2000 Dec; 83(6):502-5. PubMed ID: 11087286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
    Mukattash T; Hawwa AF; Trew K; McElnay JC
    Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
    Turner S; Nunn AJ; Fielding K; Choonara I
    Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
    Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
    Ufer M; Kimland E; Bergman U
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
    Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    Bücheler R; Meisner C; Kalchthaler B; Mohr H; Schröder H; Mörike K; Schwoerer P; Schwab M; Gleiter CH
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2551-7. PubMed ID: 12457324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of unlicensed and off-label prescription in children.
    Langerová P; Vrtal J; Urbánek K
    Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
    Cuzzolin L; Atzei A; Fanos V
    Expert Opin Drug Saf; 2006 Sep; 5(5):703-18. PubMed ID: 16907660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland.
    Craig JS; Henderson CR; Magee FA
    Ir Med J; 2001 Sep; 94(8):237-40. PubMed ID: 11758625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
    Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label prescribing during pregnancy in France: the NéHaVi cohort
.
    Laroche ML; Blin A; Coubret A; Grau M; Roux B; Aubard Y
    Int J Clin Pharmacol Ther; 2020 Apr; 58(4):198-208. PubMed ID: 31933473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.